GlassScriptPhysician profile
Lina M Millan
NPI 1578721155
$8,686.55
in general payments reported to CMS, 2019-2025
32 companies · $453 in 2025
The $453 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $377 · 2021: $685 · 2022: $5,181 · 2023: $256 · 2024: $1,379 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076 · Education: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,075.50 |
| Education | $1,013.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,836.47 | 2022-2024 | Da Vinci Surgical System |
| Abbvie INC. | $693.85 | 2019-2025 | |
| Astellas Pharma US INC | $386.94 | 2021-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $230.78 | 2019-2022 | |
| Exeltis, USA INC. | $178.54 | 2020-2022 | |
| Ethicon US, LLC | $152.73 | 2019-2021 | |
| Medtronic, INC. | $125.66 | 2024-2025 | Truclear |
| Hologic Sales and Service, LLC | $117.12 | 2020-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Aspira Women'S Health INC | $110.08 | 2021 | |
| Mayne Pharma Commercial LLC | $92.00 | 2021-2025 | |
| Myovant Sciences INC. | $91.77 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $88.57 | 2023-2025 | Myfembree, Gemtesa |
| Boston Scientific Corporation | $71.14 | 2024-2025 | Varithena Administration Pack, Advantage System |
| Therapeuticsmd, INC. | $51.48 | 2019-2021 | |
| Coloplast Corp | $45.29 | 2023-2024 | Altis |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $41.69 | 2020-2021 | |
| Agile Therapeutics, INC. | $41.39 | 2021-2022 | |
| Millicent US INC | $31.03 | 2020-2024 | |
| Lupin INC. | $30.07 | 2019-2020 | |
| Allergan, INC. | $29.04 | 2019 | |
| Axonics, INC. | $28.58 | 2023 | Bulkamid |
| Coopersurgical, INC. | $26.97 | 2019 | |
| Roche Diagnostics Corporation | $23.06 | 2019 | |
| Evofem Biosciences, INC. | $22.68 | 2022 | |
| Olympus America INC. | $22.09 | 2024 | Olympus |
| Pacira Pharmaceuticals Incorporated | $20.40 | 2020 | |
| Organon LLC | $19.61 | 2021 | |
| Conmed Corporation | $18.82 | 2025 | Airseal |
| Daiichi Sankyo INC. | $17.39 | 2019 | |
| Baxter Healthcare | $14.44 | 2024 | Perclot |
| Vertical Pharmaceuticals, LLC | $13.57 | 2019 | |
| Meditrina | $13.30 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lina Millan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.